The Recall Desk
HighFDA (Drugs)·D-0393-2025·Announced 2025-05-07

[pending] WEGOVY (SEMAGLUTIDE)

Pending LLM rewrite. Source: FDA_DRUG D-0393-2025.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: Pending LLM scoring against the rubric.

Plain-English summary

Temperature abuse: Wegovy product was potentially exposed to temperatures outside of the products labeled storage conditions due to a shipping error involving a Cardinal Health distribution center. More specifically, product was removed from refrigerated storage for an extended period of time and inappropriately released.

The recalled product

Product
WEGOVY (SEMAGLUTIDE)
Brand
WEGOVY
Manufacturer
Cardinal Health Inc.

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot PZFDE06
  • Exp 08/31/2025

Distribution

Distributed in 3 states:

  • NC
  • SC
  • VA